Guardant Health, Inc. (GH) vs Mettler-Toledo International, Inc. (MTD)
- Guardant Health, Inc. GH 154.16 −8.55%
- Mettler-Toledo International, Inc. MTD 1,676.92 −2.69%
Guardant Health, Inc. and Mettler-Toledo International, Inc. are both Diagnostics & Research companies. Mettler-Toledo International, Inc. is the larger, with a market value of $33.6B against $20.6B — 1.6× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Mettler-Toledo International, Inc. trades at 37.6×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against 6.91%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs −37.9%) and the higher return on invested capital (35.4% vs −25.7%). Across the 18 metrics below, Mettler-Toledo International, Inc. leads on 10 and Guardant Health, Inc. on 8.
Valuation
Profitability
| Metric | GH | MTD | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.19% | 60.26% | 48.32% |
| Operating margin | (39.41%) | 28.41% | (5.68%) |
| Net margin | (37.93%) | 21.91% | (4.10%) |
| Free cash flow margin | (18.15%) | 20.90% | 0.00% |
| Return on equity | 153.90% | (736.36%) | 0.00% |
| Return on assets | (30.68%) | 25.61% | (6.05%) |
| Return on invested capital | (25.68%) | 35.40% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack